Follow
Michaela Fojtů
Michaela Fojtů
Researcher, Masaryk University
Verified email at muni.cz
Title
Cited by
Cited by
Year
Two-dimensional materials in biomedical, biosensing and sensing applications
N Rohaizad, CC Mayorga-Martinez, M Fojtů, NM Latiff, M Pumera
Chemical Society Reviews 50 (1), 619-657, 2021
3892021
Environmental impact and potential health risks of 2D nanomaterials
M Fojtů, WZ Teo, M Pumera
Environmental Science: Nano 4 (8), 1617-1633, 2017
1032017
Unexpected therapeutic effects of cisplatin
M Raudenska, J Balvan, M Fojtu, J Gumulec, M Masarik
Metallomics 11 (7), 1182-1199, 2019
962019
Black phosphorus nanoparticles potentiate the anticancer effect of oxaliplatin in ovarian cancer cell line
M Fojtů, X Chia, Z Sofer, M Masařík, M Pumera
Advanced Functional Materials 27 (36), 1701955, 2017
682017
Graphene oxide nanoplatelets potentiate anticancer effect of cisplatin in human lung cancer cells
NF Rosli, M Fojtů, AC Fisher, M Pumera
Langmuir 35 (8), 3176-3182, 2019
642019
Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: a review
M Fojtu, J Gumulec, T Stracina, M Raudenska, A Skotakova, ...
Current drug metabolism 18 (3), 237-263, 2017
512017
Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages
J Gumulec, M Fojtu, M Raudenska, M Sztalmachova, A Skotakova, ...
International Journal of Molecular Sciences 15 (12), 22960-22977, 2014
482014
Engine shutdown: migrastatic strategies and prevention of metastases
M Raudenská, K Petrláková, T Juriňáková, JL Fialová, M Fojtů, M Jakubek, ...
Trends in Cancer 9 (4), 293-308, 2023
372023
Pollen‐Based Magnetic Microrobots are Mediated by Electrostatic Forces to Attract, Manipulate, and Kill Cancer Cells
CC Mayorga‐Martinez, M Fojtů, J Vyskočil, NJ Cho, M Pumera
Advanced Functional Materials 32 (46), 2207272, 2022
342022
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor
S Hudecova, J Markova, V Simko, L Csaderova, T Stracina, M Sirova, ...
Oncotarget 7 (38), 61403, 2016
312016
Oxidized polysaccharides for anticancer-drug delivery: What is the role of structure?
L Münster, M Fojtů, Z Capáková, M Muchová, L Musilová, T Vaculovič, ...
Carbohydrate Polymers 257, 117562, 2021
272021
Black phosphorus cytotoxicity assessments pitfalls: advantages and disadvantages of metabolic and morphological assays
M Fojtů, J Balvan, M Raudenská, T Vičar, D Bouša, Z Sofer, M Masařík, ...
Chemistry–A European Journal 25 (1), 349-360, 2019
262019
Prognostic significance of the tumour-adjacent tissue in head and neck cancers
M Raudenska, M Sztalmachova, J Gumulec, M Fojtu, H Polanska, ...
Tumor Biology 36, 9929-9939, 2015
262015
Selectively oxidized cellulose with adjustable molecular weight for controlled release of platinum anticancer drugs
L Münster, M Fojtů, Z Capáková, T Vaculovič, M Tvrdoňová, ...
Biomacromolecules 20 (4), 1623-1634, 2019
242019
Locked and Loaded: Ruthenium(II)-Capped Cucurbit[n]uril-Based Rotaxanes with Antimetastatic Properties
M Sojka, M Fojtu, J Fialova, M Masarik, M Necas, R Marek
Inorganic Chemistry 58 (16), 10861-10870, 2019
222019
Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients
H Polanska, M Raudenska, K Hudcová, J Gumulec, M Svobodova, ...
Oncology letters 12 (3), 2127-2132, 2016
182016
Different doxorubicin formulations affect plasma 4-hydroxy-2-nonenal and gene expression of aldehyde dehydrogenase 3A1 and thioredoxin reductase 2 in rat
M Hlavacova, J Gumulec, T Stracina, M Fojtu, M Raudenská, M Masarik, ...
Physiological Research 64, S653, 2015
152015
2d germanane derivative as a vector for overcoming doxorubicin resistance in cancer cells
M Fojtů, J Balvan, M Raudenská, T Vičar, J Šturala, Z Sofer, J Luxa, ...
Applied Materials Today 20, 100697, 2020
142020
Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations
M Svobodova, M Raudenska, J Gumulec, J Balvan, M Fojtu, ...
Oncotarget 8 (39), 66254, 2017
122017
Silicane derivative increases doxorubicin efficacy in an ovarian carcinoma mouse model: fighting drug resistance
M Fojtů, J Balvan, T Vicar, HH Polanská, B Peltanová, S Matejkova, ...
ACS Applied Materials & Interfaces 13 (27), 31355-31370, 2021
102021
The system can't perform the operation now. Try again later.
Articles 1–20